Cargando…

Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data

BACKGROUND: Cardiovascular diseases are the main cause of death worldwide, making their prevention a major health care challenge. In 2006, a German statutory health insurance company presented a novel individualised prevention programme (KardioPro), which focused on coronary heart disease (CHD) scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aljutaili, Majed, Becker, Christian, Witt, Sabine, Holle, Rolf, Leidl, Reiner, Block, Michael, Brachmann, Johannes, Silber, Sigmund, Bestehorn, Kurt, Stollenwerk, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086686/ https://www.ncbi.nlm.nih.gov/pubmed/24938674 http://dx.doi.org/10.1186/1472-6963-14-263

Ejemplares similares

The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
por: Witt, Sabine, et al.
Publicado: (2014)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2013)

Gynaecomastia Surgery: Should it be Individualised?
por: Ghnnam, Wagih Mommataz
Publicado: (2014)

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2012)

Costs and effects of intra-operative fluorescence molecular imaging – A model-based, early assessment
por: Präger, Maximilian, et al.
Publicado: (2018)

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany
por: Lungen, Markus, et al.
Publicado: (2008)

Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013–2014
por: Schmidt, Christian, et al.
Publicado: (2021)

The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study
por: Wacker, Margarethe, et al.
Publicado: (2013)

Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approach
por: Stark, Renee G, et al.
Publicado: (2011)

Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study
por: Meisinger, Christa, et al.
Publicado: (2013)

Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges
por: van Leuven, Jason, et al.
Publicado: (2023)

Breast Cancer Attributable Costs in Germany: A Top-Down Approach Based on Sickness Funds Data
por: Gruber, Emil Victor, et al.
Publicado: (2012)

Myocardial Perfusion SPECT and ATTR imaging 2021 in Germany: Results of the 9th Survey
por: Lindner, Oliver, et al.
Publicado: (2023)

Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
por: Gitt, Anselm K., et al.
Publicado: (2010)

Effects of a 3-Year Nurse-Based Case Management in Aged Patients with Acute Myocardial Infarction on Rehospitalisation, Mortality, Risk Factors, Physical Functioning and Mental Health. A Secondary Analysis of the Randomized Controlled KORINNA Study
por: Kirchberger, Inge, et al.
Publicado: (2015)

Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
por: Lutter, Johanna I., et al.
Publicado: (2019)

Preoperative patients’ health decrease moderately, while hospital costs increase for hip and knee replacement due to the first COVID-19 lockdown in Germany
por: Schatz, Caroline, et al.
Publicado: (2022)

Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level
por: Bestehorn, Kurt, et al.
Publicado: (2011)

Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
por: Bestehorn, Kurt, et al.
Publicado: (2009)

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
por: Hoermann, Rudolf, et al.
Publicado: (2019)

A pilot study on patient-related costs and factors associated with the cost of specialist palliative care in the hospital: first steps towards a patient classification system in Germany
por: Becker, Christian, et al.
Publicado: (2018)

National Insurance in Germany and Great Britain
Publicado: (1912)

Towards individualisation of treatment in endometrial cancer
por: Taylor, S E, et al.
Publicado: (2012)

Individualised aspiration dynamics: Calculation by proofs
por: Wu, Bin, et al.
Publicado: (2018)

The routine pre-employment screening chest radiograph: Should it be routine?
por: Samuel, V John, et al.
Publicado: (2016)

Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting
por: Völler, Heinz, et al.
Publicado: (2006)

Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
por: Di, Mengyang, et al.
Publicado: (2020)

Immediate and Long-Term Therapy of Patients with Acute Coronary Syndromes with Thienopyridines. Current Status According to the Latest European Society of Cardiology (ESC) Guidelines
por: Silber, Sigmund
Publicado: (2011)

Herzinsuffizienz: Prognose schlechter als die von Krebs
por: Silber, Sigmund
Publicado: (2022)

COVID-19 erhöht kardiovaskuläre Risiken teils dramatisch
por: Silber, Sigmund
Publicado: (2022)

Wirklich gesund? So bestimmt man das persönliche kardiovaskuläre Risiko
por: Silber, Sigmund
Publicado: (2022)

Transplant ureter should be stented routinely
por: Mongha, Ritesh, et al.
Publicado: (2010)

Effect of Insurance Legislation on National Character in Germany
Publicado: (1913)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Enabling individualised health in learning healthcare systems
por: Wongvibulsin, Shannon, et al.
Publicado: (2020)

Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
por: Willowson, Kathy P., et al.
Publicado: (2021)

Individualised prescription of medications for treatment of obesity in adults
por: Hocking, Samantha, et al.
Publicado: (2023)

Commentary to the article “Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020”
por: Bestehorn, Kurt
Publicado: (2022)

Protocol for the INFORMED (Individualised Patient Care and Treatment for Maternal Diabetes) Study: a randomised controlled trial embedded within routine care
por: Dingena, Cassy F, et al.
Publicado: (2023)

Fundamental Investigations into Metoprolol Tartrate Deposition on Orodispersible Films by Inkjet Printing for Individualised Drug Dosing
por: Kiefer, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7p0qljj56dtidqnqoilqh3oam